GoldenGolden
Advanced Search
Stellar Biotechnologies

Stellar Biotechnologies

Stellar Biotechnologies is a company developing targeted immune therapies and immunodiagnostics.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

April 11, 2013
Stellar Biotechnologies raises a $1,613,700 seed round.
October 31, 2012
Stellar Biotechnologies raises a $1,005,800 series A round.

Funding rounds

People

Name
Role
LinkedIn

Jensen Fleming

Employee

Mike Klein

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.